CLS Holdings USA Inc (CLSH)
0.054
0.00 (0.00%)
USD |
OTCM |
Apr 26, 15:59
CLS Holdings USA Total Assets (Quarterly): 9.130M for Feb. 29, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| February 29, 2024 | 9.130M |
| November 30, 2023 | 10.69M |
| August 31, 2023 | 10.27M |
| May 31, 2023 | 10.07M |
| February 28, 2023 | 14.38M |
| November 30, 2022 | 15.52M |
| August 31, 2022 | 15.28M |
| May 31, 2022 | 15.83M |
| February 28, 2022 | 14.37M |
| November 30, 2021 | 12.54M |
| August 31, 2021 | 12.08M |
| May 31, 2021 | 11.60M |
| February 28, 2021 | 10.60M |
| November 30, 2020 | 14.40M |
| August 31, 2020 | 14.91M |
| May 31, 2020 | 15.27M |
| February 29, 2020 | 41.18M |
| November 30, 2019 | 43.31M |
| August 31, 2019 | 43.85M |
| May 31, 2019 | 46.50M |
| February 28, 2019 | 48.83M |
| November 30, 2018 | 39.41M |
| Date | Value |
|---|---|
| August 31, 2018 | 35.20M |
| May 31, 2018 | 2.105M |
| February 28, 2018 | 2.11M |
| November 30, 2017 | 0.3235M |
| August 31, 2017 | 0.0154M |
| May 31, 2017 | 0.1319M |
| February 28, 2017 | 0.223M |
| November 30, 2016 | 0.2428M |
| August 31, 2016 | 0.1814M |
| May 31, 2016 | 0.2553M |
| February 29, 2016 | 0.14M |
| November 30, 2015 | 0.1096M |
| August 31, 2015 | 0.1352M |
| May 31, 2015 | 0.2928M |
| February 28, 2015 | 0.0025M |
| November 30, 2014 | |
| August 31, 2014 | 0.00 |
| May 31, 2014 | 0.00 |
| February 28, 2014 | 0.00 |
| November 30, 2013 | 0.00 |
| August 31, 2013 | 0.00 |
| May 31, 2013 | 0.00 |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
9.130M
Minimum
Feb 2024
46.50M
Maximum
May 2019
19.09M
Average
14.39M
Median
Total Assets (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 9.034M |
| Palatin Technologies Inc | 13.55M |
| iBio Inc | 34.02M |
| Theriva Biologics Inc | 55.22M |
| Oragenics Inc | 4.966M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 20.65M |
| Shareholders Equity (Quarterly) | -10.38M |
| Debt to Equity Ratio | -0.6786 |
| Current Ratio | 0.3046 |
| Net Debt Paydown Yield | 15.81% |